Overexpression of p53, c-erbB-2 and epidermal growth factor receptor in human breast carcinomas

Pathology International

Volumn 46, Issue 1, 1996, Pages 46-53

  Suzuki, Masatsugu ^a,b   Okuyama, Takazo ^a   Yoshikawa, Kiyotsugu ^a   Yamaoka, Yoshio ^a   Ariyasu, Tetsuya ^a   Fujita, Masayuki ^a   Tankawa, Hidemitsu ^b   Sugiyama, Taketoshi ^c   Takahashi, Rei ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^c Shiga Medical Center for Adult Diseases   (Japan)

Author keywords

breast carcinoma; c erbB 2; EGF R; immunohistochemistry; p53

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN; PROTEIN P53;

ARTICLE; BREAST CARCINOMA; CANCER GRADING; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE C ERB; PRIORITY JOURNAL;

EID: 0029929751     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1996.tb03532.x     Document Type: Article

References (32)

1. Levine AJ, Momad J, Finlay CA. The p53 tumor suppressor gene. Nature 1991; 351: 453-456.
2. Nigro JM, Baker S, Preisinger AC et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989; 342: 705-708.
3. Prosser J, Thompson AM, Cranston G, Evans HJ. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. Oncogene 1990; 5: 1573-1579.
4. Thompson AM, Steel CM, Chetty U et al. p53 gene mRNA expression and chromosome 17p allele loss in breast cancer. Br. J. Cancer 1990; 61: 74-78.
5. Casey G, Lo-Hosueh M, Lopez ME, Vogelstein B, Stanbridge EJ. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene 1991; 6: 1791-1797.
6. Bacus SS, Ruby SG, Weinberg DS, Chin D, Ortiz R, Bacus JW. HER-2/neu oncogene expression and proliferation in breast cancer. Am. J. Pathol. 1990; 137: 103-111.
7. Berger MS, Locker GW, Saurer S et al. Correlation of c-erbB-1 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res. 1988; 48: 1238-1243.
8. Iglehart J, Kraus MH, Langton BC, Huper G, Kerns BJ, Marks JR. Increased erbB-2 gene copies and expression in multiple stages of breast cancer. Cancer Res. 1990; 50: 6701-6707.
9. Maguire HC, Greene MI. The neu(c-erbB-2) oncogene. Semin. Oncol. 1989; 16: 148-155.
10. Slamon DJ, Godolphin W, Jones LA et al. Studies of the HER-s/ neu proto-oncogene in human breast cancer. N. Engl. J. Med. 1989; 244: 707-712.
11. Van De Vijver MJ, Petere JL, Mooi WJ et al. Neu-protein overexpression in breast cancer. N. Engl. J. Med. 1988; 319: 1239-1245.
12. Van Diest PJ, Baak JPA, Chin D, Theeuwes JW, Bacus SS. Quantitation of Her-2/neu oncoprotein overexpression in invasive breast cancer by image analysis: A study comparing fresh and paraffin-embedded material. Anal. Cell. Pathol. 1991; 3: 195-202.
13. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177-182.
14. McCann AH, Dervan PA, O'Regan M et al. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer. Cancer Res. 1991; 51: 3296-3303.
15. Thor AD, Schwartz LH, Koerner FC et al. Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up. Cancer Res. 1989; 49: 7147-7152.
16. Heintz NJ, Leslie KO, Rogers LA, Howard PL. Amplification of the c-erbB-2 oncogene and prognosis of breast adenocarcinoma. Arch. Pathol. Lab. Med. 1990; 114: 160-163.
17. Foekens JA, Portengen H, Van Putten WLJ et al. Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. Cancer Res. 1989; 49: 7002-7009.
18. Umekita Y, Enokizono N, Dagara Y et al. Immunohistochemical studies on oncogene products (EGF-r, c-erbB-2) and growth factors (EGF, TGF-alfa) in human breast cancer: Their relationship to oestrogen receptor status, histological grade mitotic index and nodal status. Virchows Arch. A Pathol. Aat. Histopathol. 1992; 420: 345-351.
19. Lebeau J, Goubin G. Amplification of the epidermal growth factor receptor gene in the BT20 breast cancer cell line. Int. J. Cancer 1987; 40: 189-1991.
20. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer: A study of 1409 cases of which 359 have been followed for 15 years. Br. J. Cancer 1957; 11: 359-377.
21. Ostrowski JL, Sawan A, Henry L et al. p53 expression in human breast cancer related to survival and prognostic factors: An immunohistochemical study. J. Pathol. 1991; 164: 75-78.
22. Habuchi T, Takahashi R, Yamada H et al. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Res. 1993; 53: 3795-3799.
23. Ishikawa J, Maeda S, Umezu T et al. Amplification and overexpression of the epidermal growth factor receptor gene in human renal-cell carcinoma. Int. J. Cancer 1990; 45: 1018-1021.
24. Cattoretti G, Rilke F, Andreola S, D'Amato L, Delia D. p53 expression in breast cancer. Int. J. Cancer 1988; 41: 178-183.
25. Umekita Y, Kobayashi K, Saheki T, Yoshida H. Nuclear accumulation of p53 protein correlated with mutations in the p53 gene on archival paraffin-embedded tissues of human breast cancer. Jpn. J. Cancer Res. 1994; 85: 825-830.
26. Fukushima T, Urazumi K, Inoue N et al. Significance of overexpression of p53 protein in human breast cancer: A clinicopathological study. Jpn. J. Cancer Clin. 1983; 39: 23-27.
27. Poller DN, Hutchings CE, Galea M et al. p53 protein expression in human breast carcinoma: Relationship to expression, of epidermal growth factor receptor, c-erbB-2 protein overexpression and oestrogen receptor. Br. J. Cancer 1992; 66: 583-588.
28. Davidoff AM, Herndon JE, Glover NS et al. Relation between p53 overexpression and established prognostic factors in breast cancer. Surgery 1991; 110: 259-264.
29. Horak E, Smith K, Bromley L et al. Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer. Oncogene 1991; 6: 2277-2284.
30. Walker RA, Dearing SJ, Lane DP, Varley JM. Expression of p53 protein in infiltrating and in situ breast carcinomas. J. Pathol. 1991; 165: 203-211.
31. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 1992; 355: 846-847.
32. Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194: 23-28.